Chitosan-Based Nanoparticles for Targeted Nasal Galantamine Delivery as a Promising Tool in Alzheimer's Disease Therapy
Natural alkaloid galantamine is widely used for the treatment of mild to moderate Alzheimer's dementia. Galantamine hydrobromide (GH) is available as fast-release tablets, extended-release capsules, and oral solutions. However, its oral delivery can cause some unwanted side effects, such as gas...
Saved in:
Main Authors: | Dilyana Georgieva (Author), Denitsa Nikolova (Author), Elena Vassileva (Author), Bistra Kostova (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
HPMC-based fast-dissolving oral films with galantamine-loaded chitosan nanoparticles
by: Dilyana Georgieva, et al.
Published: (2024) -
Hierarchical Porous Carbon-PLLA and PLGA Hybrid Nanoparticles for Intranasal Delivery of Galantamine for Alzheimer's Disease Therapy
by: Stavroula G. Nanaki, et al.
Published: (2020) -
Interpenetrating Polymer Networks of Poly(2-hydroxyethyl methacrylate) and Poly(N, N-dimethylacrylamide) as Potential Systems for Dermal Delivery of Dexamethasone Phosphate
by: Marin Simeonov, et al.
Published: (2023) -
Chitosan-Coated Nanoparticles: Effect of Chitosan Molecular Weight on Nasal Transmucosal Delivery
by: Franciele Aline Bruinsmann, et al.
Published: (2019) -
Mechanistic insights into MARK4 inhibition by galantamine toward therapeutic targeting of Alzheimer's disease
by: Mohd Adnan, et al.
Published: (2023)